Medicare Enrolled
Dr. Srilatha Kothandaraman, M.D.
Rheumatology · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kothandaraman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kothandaraman?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kothandaraman
Dr. Srilatha Kothandaraman is a rheumatology specialist in Dallas, TX, with 15 years of NPI registration. Based on federal Medicare data, Dr. Kothandaraman performed 111,835 Medicare services across 2,789 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kothandaraman received a total of $119,860 from 34 pharmaceutical and/or device companies across 1122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kothandaraman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 15 years in practice
▲ Top 13% volume in TX
$119,860 industry payments
Medicare Practice Summary
Medicare Utilization ↗111,835
Medicare services
Top 13% in TX for rheumatology
2,789
Unique beneficiaries
$7
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~7,456 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
58,800 | $4 | $5 |
| Tocilizumab injection (Actemra) | 30,120 | $4 | $7 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
12,400 | $11 | $14 |
| Denosumab injection (Prolia/Xgeva) | 3,901 | $18 | $23 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
975 | $88 | $130 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
778 | $10 | $12 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
746 | $4 | $5 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
706 | $8 | $9 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
607 | $5 | $6 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
395 | $3 | $3 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
379 | $56 | $76 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
184 | $12 | $18 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
176 | $49 | $68 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
155 | $3 | $4 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
138 | $115 | $182 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
137 | $28 | $30 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
124 | $1 | $1 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
114 | $96 | $142 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
95 | $29 | $38 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
79 | $22 | $29 |
| Bone density scan (DEXA) A test that uses low-dose X-rays to measure bone mineral density in the hip, pelvis, and spine. It helps assess bone strength and risk of fractures. |
62 | $38 | $51 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
61 | $2 | $4 |
| Trabecular bone score calculation This procedure calculates the trabecular bone score using imaging data to assess bone microarchitecture. It includes interpretation and a report on fracture risk. |
49 | $32 | $43 |
| X-ray of hand, 2 views An X-ray imaging test of the hand using two different angles to visualize the bones and joints. |
47 | $24 | $32 |
| New patient office visit, complex (60-74 min) | 45 | $153 | $226 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
43 | $16 | $18 |
| Complete blood count (CBC), automated An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood. |
43 | $6 | $7 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
37 | $13 | $14 |
| Iron level test | 35 | $6 | $6 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
35 | $9 | $9 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
32 | $15 | $15 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
32 | $14 | $15 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
32 | $12 | $12 |
| Complement function test A blood test that measures the activity of complement proteins, which are part of the immune system. |
32 | $12 | $12 |
| Wrist X-ray, 2 views An X-ray imaging test of the wrist using two different angles to visualize the bones and joints. |
30 | $26 | $35 |
| Knee X-ray, 1-2 views An X-ray imaging test of the knee joint using one to two different angles to visualize the bones and surrounding structures. |
30 | $25 | $40 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
29 | $7 | $8 |
| Thyroid hormone evaluation A blood test to measure the levels of thyroid hormones in the body. This evaluation helps assess how well the thyroid gland is functioning. |
29 | $6 | $9 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
25 | $6 | $8 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
18 | $28 | $36 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $62 | $92 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
17 | $3 | $3 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
16 | $69 | $70 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
16 | $17 | $17 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
13 | $4 | $5 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
83.9% medium
4.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$119,860
Total received (2018-2024)
Avg $17,123/year across 7 years
Top 6% in TX for rheumatology
34
Companies
1,122
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$110,161 (91.9%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,699 (8.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$34,431
2023
$10,958
2022
$17,232
2021
$6,571
2020
$15,157
2019
$21,064
2018
$14,447
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ABBVIE INC.
$58,886
AbbVie, Inc.
$32,735
AbbVie Inc.
$18,539
Amgen Inc.
$1,831
Novartis Pharmaceuticals Corporation
$1,372
Janssen Biotech, Inc.
$1,105
GlaxoSmithKline, LLC.
$931
PFIZER INC.
$866
UCB, Inc.
$508
AstraZeneca Pharmaceuticals LP
$456
E.R. Squibb & Sons, L.L.C.
$438
Horizon Therapeutics plc
$424
Genentech USA, Inc.
$331
Lilly USA, LLC
$261
Boehringer Ingelheim Pharmaceuticals, Inc.
$208
GENZYME CORPORATION
$191
Celgene Corporation
$165
Aurinia Pharma U.S., Inc.
$127
TerSera Therapeutics LLC
$59
Antares Pharma, Inc.
$57
DePuy Synthes Sales Inc.
$53
West-Ward Pharmaceuticals
$42
Hikma Pharmaceuticals USA
$40
Radius Health, Inc.
$39
MEDAC PHARMA, INC.
$34
SCILEX PHARMACEUTICALS INC.
$23
Alexion Pharmaceuticals, Inc.
$22
HOSPIRA, INC.
$21
Gilead Sciences, Inc.
$20
ANI Pharmaceuticals, Inc.
$19
Organon LLC
$19
Merck Sharp & Dohme Corporation
$14
Kiniksa Pharmaceuticals International, plc
$13
Mission Pharmacal Company
$12
Top 3 companies account for 91.9% of total payments
Associated products mentioned in payments ›
AMJEVITA · AVSOLA · Actemra · Aquoral · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · EVENITY · EVUSHELD · Enbrel · HUMIRA · Humira · KEVZARA · KRYSTEXXA · LUPKYNIS · MONOVISC · Mitigare · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · ORENCIA · ORTHOVISC · Otezla · Otrexup · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · Quzyttir · RAYOS · REMICADE · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · Tavneos · Tymlos · XELJANZ · ZTLido
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (92%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in rheumatology and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 6% for rheumatology in TX.
Equivalent to $107 per 100 Medicare services performed
Geographic Context
Rheumatologists within 10 mi
95
Per 100K population
3.6
County median income
$74,149
Nearest hospital
BAYLOR UNIVERSITY MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Kothandaraman is a mixed practice specialist, with above-average Medicare volume (top 13% in TX), with speaking/promotional industry engagement in the top 6% of TX peers, with 15 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Kothandaraman experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Kothandaraman performed 58,800 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kothandaraman receive payments from pharmaceutical companies?
Yes. Dr. Kothandaraman received a total of $119,860 from 34 companies across 1,122 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kothandaraman's costs compare to other rheumatologists in Dallas?
Dr. Kothandaraman's average Medicare payment per service is $7. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kothandaraman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Rheumatologists in Dallas
Browse rheumatologists in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Rheumatologists in TX
Rheumatologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Rheumatologists in TX
Which TX rheumatologists receive the most from drug and device companies.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology